Iantrek_RBG.png
Iantrek Announces Peer-Reviewed Publication Highlighting 12-Month Safety and Effectiveness Results for its Bio-Interventional Uveoscleral Outflow Technology in Open-Angle Glaucoma Patients
10. Dezember 2024 08:00 ET | Iantrek, Inc.
White Plains, Dec. 10, 2024 (GLOBE NEWSWIRE) -- White Plains, NY – December 10, 2024 – Iantrek, Inc., a venture-backed, medical technology company pioneering next-generation bio- and...
iSTAR Medical logo.png
iSTAR Medical continues to strengthen US presence with appointment of Chief Medical Officer and Vice President of Clinical Affairs
04. September 2024 07:00 ET | iSTAR Medical
For immediate release iSTAR Medical continues to strengthen US presence with appointment of Chief Medical Officer and Vice President of Clinical Affairs WAVRE, Belgium — 4 September 2024: iSTAR...
HEX_photo Paul Harasymowycz
Hexiris Welcomes Dr. Paul Harasymowycz to Its Scientific Committee
02. April 2024 07:00 ET | Hexiris Inc.
DIEPPE, New Brunswick, April 02, 2024 (GLOBE NEWSWIRE) -- Hexiris Inc. (“Hexiris” or the “Company”), a medical device firm dedicated to advancing and simplifying Minimally Invasive Glaucoma Surgery...
Dr Ike Ahmed
Hexiris Pharma Welcomes World-Renowned Ophthalmologist Dr. Ike Ahmed to its Scientific Committee
30. Oktober 2023 07:30 ET | Hexiris Inc.
DIEPPE, New Brunswick, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Hexiris Pharma Inc. (“Hexiris Pharma” or the “Company”), a pharmaceutical firm dedicated to advancing and simplifying Minimally Invasive...
Iantrek logo and byline tight.jpg
12-month clinical results of a novel micro-interventional bio-stenting procedure published in the British Journal of Ophthalmology
23. Januar 2023 08:00 ET | Iantrek, Inc.
WHITE PLAINS, N.Y., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Iantrek today announced the publication of 12-month clinical results of a novel bio-stenting procedure using the company’s microsurgical...
iSTAR Medical logo.png
iSTAR Medical Expands Commercial Rollout of MINIject with First Surgeries in Sweden and Norway
01. Dezember 2022 03:00 ET | iSTAR Medical
For immediate release iSTAR Medical Expands Commercial Rollout of MINIject with First Surgeries in Sweden and Norway The only commercially available MIGS device currently targeting the supraciliary...
Iantrek logo and byline tight.jpg
Iantrek Raises $23M Series B Financing to Advance Next Generation Ophthalmic Micro-Interventional Technologies
30. August 2022 08:00 ET | Iantrek, Inc.
WHITE PLAINS, N.Y., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Iantrek, Inc., a medical device company founded by ophthalmic innovator Dr. Sean Ianchulev, announced the closing of a $23M Series B financing....
SION still
Sight Sciences Introduces the SION™ Surgical Instrument – The First Bladeless Device Used in Goniotomy
23. August 2022 08:03 ET | Sight Sciences, Inc.
MENLO PARK, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative solutions intended to...
SightSciences_Logo_2C_RGB.png
Sight Sciences Announces Long-Term Safety and Effectiveness Data of Standalone Use of the OMNI® Surgical System in Patients with Open Angle Glaucoma
16. August 2022 08:01 ET | Sight Sciences, Inc.
MENLO PARK, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative solutions intended to...